دورية أكاديمية
1223P First-line lenvatinib (Len) + pembrolizumab (Pembro) + chemotherapy (Chemo) vs chemo in advanced/metastatic gastroesophageal adenocarcinoma: LEAP-015 safety run-in
| العنوان: | 1223P First-line lenvatinib (Len) + pembrolizumab (Pembro) + chemotherapy (Chemo) vs chemo in advanced/metastatic gastroesophageal adenocarcinoma: LEAP-015 safety run-in |
|---|---|
| المؤلفون: | Shitara, K., Ben-Aharon, I., Rojas, C., Acosta Eyzaguirre, D.A., Hubert, A., Araya Moya, H., Cohen, D., Bai, L-Y., Ghiringhelli, F., Wyrwicz, L., Janjigian, Y.Y., Tabernero, J., Van Cutsem, E., Qin, S., Xu, J., Wang, A., Miller, M.G., Shih, C-S., Bhagia, P., Yanez Weber, P.E. |
| المصدر: | Annals of Oncology ; volume 33, page S1108 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2022 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Oncology, Hematology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.annonc.2022.07.1341 |
| الإتاحة: | https://doi.org/10.1016/j.annonc.2022.07.1341Test https://api.elsevier.com/content/article/PII:S0923753422031921?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0923753422031921?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://www.elsevier.com/open-access/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.4AB0FB72 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.annonc.2022.07.1341 |
|---|